What does BIOCLI CONSULT do?

BIOCLI CONSULT is a research organisation in Jurbise. Private Limited, started on 11 July 2021, 1 establishment.

What is the address of BIOCLI CONSULT?

The registered office of BIOCLI CONSULT is located at Chemin du Prince(EL) 161, 7050 Jurbise.

Is BIOCLI CONSULT still active?

Yes. According to the CBE (30 October 2026) BIOCLI CONSULT is active, legal situation “Normale toestand”, started on 11 July 2021.

Is BIOCLI CONSULT registered on Peppol?

Yes, BIOCLI CONSULT is registered on the Peppol network with ID 0208:0770990147.

What is the enterprise number of BIOCLI CONSULT?

The enterprise number of BIOCLI CONSULT is BE0770990147.

When was BIOCLI CONSULT founded?

BIOCLI CONSULT was founded on 11 July 2021.

Is BIOCLI CONSULT a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 11 July 2021; 5 annual accounts filed, latest fiscal year 2025.

How much profit did BIOCLI CONSULT make in 2025?

BIOCLI CONSULT posted a profit after taxes of € 154,759 in financial year 2025.

What is the revenue of BIOCLI CONSULT?

As a small company, BIOCLI CONSULT is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 205,055.

BIOCLI CONSULT (Private Limited) - Jurbise - BE0770990147

Dossier BIOCLI CONSULT, printed on 30 October 2026 from databakkes.be/en/0770990147/biocli-consult. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

BIOCLI CONSULT from Jurbise, company number BE0770990147, closed financial year 2025 with a result of € 154,759 after tax. For that financial year BIOCLI CONSULT recorded a gross margin of € 205,055 and equity of € 3,019. Compared with financial year 2024, the result moved from € 129,310 to € 154,759. Profitable, and profit is growing. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2026.

What it is worth Healthy

€ 3,019

▼ 47% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 154,759

▲ 20% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 197,567

▼ 33% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 157,400 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 3,072

▲ 35% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 1,830

▼ 17% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 11,091

▲ 1% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 126,579 Gross margin 2022: € 126,579 First fiscal year in the series	€ 146,268 Gross margin 2023: € 146,268 ▲ 16% vs 2022 (€ 126,579) Favourable step	€ 170,846 Gross margin 2024: € 170,846 ▲ 17% vs 2023 (€ 146,268) Favourable step	€ 205,055 Gross margin 2025: € 205,055 ▲ 20% vs 2024 (€ 170,846) Favourable step	▲ 20%
Profit after taxes	€ 100,166 Profit after taxes 2022: € 100,166 First fiscal year in the series	€ 110,956 Profit after taxes 2023: € 110,956 ▲ 11% vs 2022 (€ 100,166) Favourable step	€ 129,310 Profit after taxes 2024: € 129,310 ▲ 17% vs 2023 (€ 110,956) Favourable step	€ 154,759 Profit after taxes 2025: € 154,759 ▲ 20% vs 2024 (€ 129,310) Favourable step	▲ 20%
Equity	€ 145,395 Equity 2022: € 145,395 First fiscal year in the series	€ 256,351 Equity 2023: € 256,351 ▲ 76% vs 2022 (€ 145,395) Favourable step	€ 5,661 Equity 2024: € 5,661 ▼ 98% vs 2023 (€ 256,351) Unfavourable step	€ 3,019 Equity 2025: € 3,019 ▼ 47% vs 2024 (€ 5,661) Unfavourable step	▼ 47%
Total debts	€ 47,500 Total debts 2022: € 47,500 First fiscal year in the series	€ 37,764 Total debts 2023: € 37,764 ▼ 20% vs 2022 (€ 47,500) Favourable step	€ 393,265 Total debts 2024: € 393,265 ▲ € 355,501 vs 2023 (€ 37,764) Unfavourable step	€ 299,756 Total debts 2025: € 299,756 ▼ 24% vs 2024 (€ 393,265) Favourable step	▼ 24%
Cash	€ 100,682 Cash 2022: € 100,682 First fiscal year in the series	€ 186,813 Cash 2023: € 186,813 ▲ 86% vs 2022 (€ 100,682) Favourable step	€ 292,863 Cash 2024: € 292,863 ▲ 57% vs 2023 (€ 186,813) Favourable step	€ 197,567 Cash 2025: € 197,567 ▼ 33% vs 2024 (€ 292,863) Unfavourable step	▼ 33%
Retained profit	€ 142,395 Retained profit 2022: € 142,395 First fiscal year in the series	€ 253,351 Retained profit 2023: € 253,351 ▲ 78% vs 2022 (€ 142,395) Favourable step	€ 2,661 Retained profit 2024: € 2,661 ▼ 99% vs 2023 (€ 253,351) Unfavourable step	€ 19 Retained profit 2025: € 19 ▼ 99% vs 2024 (€ 2,661) Unfavourable step	▼ 99%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 380,000 Dividend 2024: € 380,000 Unchanged (€ 0) Unchanged	€ 157,400 Dividend 2025: € 157,400 ▼ 59% vs 2024 (€ 380,000) Unchanged	▼ 59%
Balance sheet total	€ 192,895 Balance sheet total 2022: € 192,895 First fiscal year in the series	€ 294,114 Balance sheet total 2023: € 294,114 ▲ 52% vs 2022 (€ 192,895) Unchanged	€ 398,926 Balance sheet total 2024: € 398,926 ▲ 36% vs 2023 (€ 294,114) Unchanged	€ 302,775 Balance sheet total 2025: € 302,775 ▼ 24% vs 2024 (€ 398,926) Unchanged	▼ 24%

Key figures of BIOCLI CONSULT, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to BIOCLI CONSULT?

What happened at BIOCLI CONSULT in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 30, 2026 New annual accounts for financial year 2025: profit of € 154,759 (▲ 20% vs 2024). Source: NBB ↗
Jul 11, 2021 New establishment in Jurbise. KBO
Jul 11, 2021 Start of the company according to the CBE. KBO

In short

From € 100,166 profit in 2022 to € 154,759 profit in 2025.

Paid € 140,494 in corporate taxes since 2022.

Best year ever: 2025, with € 154,759 profit.

Paid out € 537,400 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Establishments

Establishment units

Physical locations of this company

Registered office

Chemin du Prince(EL) 161

7050 Jurbise

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0770.990.147

VAT number

BE 0770.990.147

Registered office

Chemin du Prince(EL) 161, 7050 Jurbise

Names & denominations

BIOCLI CONSULT

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

11 July 2021

Peppol

Active · Active since 3 Jan 2026

Activities · NACE

Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

Activiteiten van medische beeldvorming en medische laboratoria

Activiteiten van medische laboratoria

View on CBE Public ↗ Annual accounts (NBB) ↗